Done sou Salè H1B

Akèy › Anplwayè › Regeneron Pharmaceuticals, Inc. › Associate Director

Associate Director nan Regeneron Pharmaceuticals, Inc.: Salè H-1B

5 aplikasyon kondisyon travay pou tit travay Associate Director nan Regeneron Pharmaceuticals, Inc.. Salè baz medyàn ofri $200,000; mwatye mitan $200,000–$205,000.

Demann (LCA)5
Salè medyan ofri$200,000
Mwatye salè yo$200,000–$205,000
10yèm–90yèm pousantaj$192,594–$218,800

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20231$187,657
FY20264$202,500

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$228,000–$275,000
Nivo II		Tarrytown, NYJan 12, 2026Feb 2, 2026Certifye
$200,000–$220,000
Nivo II		Warren, NJJan 12, 2026Feb 2, 2026Certifye
$205,000–$225,000
Nivo II		Warren, NJJan 12, 2026Feb 2, 2026Certifye
$200,000–$230,000
Nivo II		Sleepy Hollow, NYJan 5, 2026Feb 2, 2026Certifye
$187,657
Nivo III		Sleepy Hollow, NYFeb 6, 2023Feb 6, 2023Certifye

Associate Director nan tout anplwayè yo →

Lòt travay nan Regeneron Pharmaceuticals, Inc.

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).